RU2017139097A3 - - Google Patents

Download PDF

Info

Publication number
RU2017139097A3
RU2017139097A3 RU2017139097A RU2017139097A RU2017139097A3 RU 2017139097 A3 RU2017139097 A3 RU 2017139097A3 RU 2017139097 A RU2017139097 A RU 2017139097A RU 2017139097 A RU2017139097 A RU 2017139097A RU 2017139097 A3 RU2017139097 A3 RU 2017139097A3
Authority
RU
Russia
Application number
RU2017139097A
Other versions
RU2017139097A (ru
RU2738969C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2017139097A publication Critical patent/RU2017139097A/ru
Publication of RU2017139097A3 publication Critical patent/RU2017139097A3/ru
Application granted granted Critical
Publication of RU2738969C2 publication Critical patent/RU2738969C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0667Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
RU2017139097A 2015-05-08 2016-05-09 Способ оценки и мониторинга in vitro чистоты препарата клеток, применение фактора роста, набор RU2738969C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562158875P 2015-05-08 2015-05-08
US62/158,875 2015-05-08
EP15179417.9 2015-07-31
EP15179417.9A EP3091084A1 (en) 2015-05-08 2015-07-31 Methods for assessing the purity of a mesenchymal stem cells preparation
PCT/EP2016/060351 WO2016180788A1 (en) 2015-05-08 2016-05-09 Methods for assesing the purity of a mesenchymal stem cells preparation

Publications (3)

Publication Number Publication Date
RU2017139097A RU2017139097A (ru) 2019-06-10
RU2017139097A3 true RU2017139097A3 (ru) 2019-08-30
RU2738969C2 RU2738969C2 (ru) 2020-12-21

Family

ID=53776427

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017139097A RU2738969C2 (ru) 2015-05-08 2016-05-09 Способ оценки и мониторинга in vitro чистоты препарата клеток, применение фактора роста, набор

Country Status (16)

Country Link
US (2) US11203785B2 (ru)
EP (2) EP3091084A1 (ru)
JP (2) JP6727291B2 (ru)
KR (1) KR20180002760A (ru)
CN (1) CN107709575B (ru)
AU (1) AU2016259736B2 (ru)
CA (1) CA2985268A1 (ru)
DK (1) DK3294904T3 (ru)
ES (1) ES2892487T3 (ru)
HK (1) HK1251620A1 (ru)
IL (1) IL255500B (ru)
MX (1) MX2017014247A (ru)
PT (1) PT3294904T (ru)
RU (1) RU2738969C2 (ru)
WO (1) WO2016180788A1 (ru)
ZA (1) ZA201707477B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200308626A1 (en) * 2017-09-29 2020-10-01 Pharmabio Corporation Quality management method for regeneration medical product or the like by using standardized expression amount
PL241520B1 (pl) * 2020-03-27 2022-10-17 Polski Bank Komorek Macierzystych Spolka Akcyjna Zastosowanie panelu genów do określania potencjału teratogennego komórek mezenchymalnych i pochodzenia perinatalnego
CN112159794B (zh) * 2020-09-17 2022-07-15 中国人民解放军空军军医大学 骨相关间充质干细胞cd166+亚群的制备及应用
US20230365937A1 (en) * 2020-10-26 2023-11-16 Hadasit Medical Research Services And Development Ltd. Mesenchymal stem cells and their culture
EP4408979A1 (en) * 2021-09-30 2024-08-07 Polski Bank Komórek Macierzystych S.A. Expression analysis of a specific gene pool to determine whether the population of adipose tissue-derived mesenchymal cells (at-msc) selected for clinical application can undergo a transformation into neoplastic cells

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010049139A1 (en) 2000-03-23 2001-12-06 Eric Lagasse Hepatic regeneration from hematopoietic stem cells
ES2325715B1 (es) * 2007-08-03 2010-06-17 Genetrix, S.L. Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca.
JP5416895B2 (ja) * 2007-10-23 2014-02-12 学校法人慶應義塾 単球由来多能性細胞(momc)の効率的な作製法
ES2351916B8 (es) * 2009-07-30 2012-07-09 Centro Nacional De Investigaciones Cardiovasculares (Cnic) Metodo de identificacion de celulas madre mesenquimales senescentes
CN103200937B (zh) 2010-09-01 2020-07-03 托马斯杰弗逊大学 用于肌肉修复和再生的组合物和方法
CN104508124B (zh) * 2011-07-06 2017-11-17 细胞治疗有限公司 中胚层谱系祖细胞
KR101751355B1 (ko) * 2011-08-24 2017-07-04 (주)아모레퍼시픽 인간 피부 진피 유래 성체 줄기세포
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof
SG11201403927XA (en) * 2012-01-13 2014-08-28 Genentech Inc Biological markers for identifying patients for treatment with vegf antagonists
JP6198199B2 (ja) * 2013-03-12 2017-09-20 美智代 津留 平行線維性結合組織の製造方法
WO2014144392A1 (en) 2013-03-15 2014-09-18 Turner Designs Hydrocarbon Instruments, Inc. Solvent-free method for measuring hydrocarbons in water
JP5889856B2 (ja) * 2013-10-15 2016-03-22 佛教慈濟醫療財團法人 生体外でヒト間葉系幹細胞を増殖させる方法、およびそれに用いる補助剤、ならびに、生体外でヒト間葉系幹細胞の成長因子を取り出す方法およびその成長因子の用途

Also Published As

Publication number Publication date
RU2017139097A (ru) 2019-06-10
HK1251620A1 (zh) 2019-02-01
JP2018522251A (ja) 2018-08-09
IL255500B (en) 2021-04-29
PT3294904T (pt) 2021-10-14
WO2016180788A1 (en) 2016-11-17
EP3294904B1 (en) 2021-08-18
MX2017014247A (es) 2018-06-28
RU2738969C2 (ru) 2020-12-21
JP6727291B2 (ja) 2020-07-22
EP3294904A1 (en) 2018-03-21
AU2016259736B2 (en) 2022-06-16
CA2985268A1 (en) 2016-11-17
EP3091084A1 (en) 2016-11-09
JP6967122B2 (ja) 2021-11-17
US20220064729A1 (en) 2022-03-03
US11203785B2 (en) 2021-12-21
IL255500A (en) 2018-01-31
CN107709575B (zh) 2022-11-15
BR112017024011A2 (pt) 2018-07-17
US20180135124A1 (en) 2018-05-17
DK3294904T3 (da) 2021-10-11
KR20180002760A (ko) 2018-01-08
JP2020173265A (ja) 2020-10-22
AU2016259736A1 (en) 2017-11-30
CN107709575A (zh) 2018-02-16
ZA201707477B (en) 2020-05-27
ES2892487T3 (es) 2022-02-04

Similar Documents

Publication Publication Date Title
BR112017027241A2 (ru)
BR112016001205A2 (ru)
BR112018004238A2 (ru)
RU2017139097A3 (ru)
BR0306523B1 (ru)
CN303074325S (ru)
CN303072311S (ru)
CN303071871S (ru)
CN303071508S (ru)
CN303071503S (ru)
CN303069135S (ru)
CN303069111S (ru)
BR0003746B1 (ru)
CN303069055S (ru)
CN303068054S (ru)
CN303067996S (ru)
CN303067897S (ru)
CN303067754S (ru)
CN303065706S (ru)
BR0205082B1 (ru)
BR0110273B1 (ru)
BR0014783B1 (ru)
BR0010150B1 (ru)
BR0009994B1 (ru)
BR0009942B1 (ru)

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20200109

FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20200207